To investigate whether tumors induce alterations in the composition of peripheral blood CD8+ T cells, we retrospectively analyzed CD8+ T cells in the PBMCs of 53 healthy donors and 349 patients with lung cancer (294 patients with NSCLC and 55 patients with SCLC) (Supplementary Table 1). This evidence concerns the gene CD8A and lung carcinoma.